Cancer Research Investments in Wisconsin: Strengthening the Economy and Saving Lives
July 13, 2011
August 11, 2011 Froedtert & The Medical College of Wisconsin Clinical Cancer Center Milwaukee, WI Read More
July 13, 2011
August 11, 2011 Froedtert & The Medical College of Wisconsin Clinical Cancer Center Milwaukee, WI Read More
July 13, 2011
August 1, 2011 Devil’s Head Resort and Conference Center Merrimac, WI Read More
July 13, 2011
Center for Advanced Technology and Innovation Medical College of Wisconsin Milwaukee County Research Park Office of Governor Scott Walker University of Wisconsin Biotechnology Center Wisconsin Biotechnology and Medical Device Association Wisconsin Department of Health Services Wisconsin Medical Society Wisconsin State Assembly Wisconsin State Legislature Wisconsin State Senate
July 13, 2011
The 2011-2012 legislative session brings an entirely new state legislature and a new Administration to Wisconsin. BioForward will be working on a variety of state issues this session, including a bioscience jobs initiative that is aimed at increasing investment in bioscience companies in Wisconsin and carefully monitoring the move toward restructuring the Department of Commerce […]
July 13, 2011
The Wisconsin Biotechnology and Medical Device Association offers video comments from biotech leaders who comment on the bioscience industry in the state. Read More
July 13, 2011
BioForward is pleased to share with you “The Contribution of the Bioscience Industry to the Wisconsin Economy,” a comprehensive analysis of the significant economic impact the bioscience industry has on Wisconsin. Indeed, the report shows that the bioscience industry is paying high wages, creating jobs and putting Wisconsin in a stronger position to transform its […]
July 13, 2011
Wisconsin can and should properly leverage the substantial economic advantages it has with this dynamic industry. The study finds credible evidence of the growing impact of bioscience throughout the state in the health, energy and agriculture sectors. Read More
June 23, 2011
Less expensive, follow-on biologics are expected to be a boon to patients and Washington’s biotechnology industry. But as the FDA implements a new approval pathway for these complicated drugs, the medical community wants to ensure patient safety comes first. Read More
June 21, 2011
November 18, 2011 Seattle, WA Read More
June 21, 2011
September 20, 2011 Institute for Stem Cell & Regenerative Medicine Seattle, WA Read More